ERBB2 and obesity due to melanocortin 4 receptor deficiency: One theory is that obesity might be associated with increased proliferation of tumor cells in patients with hormone receptor-positive/HER2-negative tumors, enhancing their chemotherapy susceptibility due to hormonal proliferation stimuli from increased adipose tissue.